Global Human Prothrombin Complex Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Human Prothrombin Complex market size will reach 2,382.90 Million USD in 2025 and is projected to reach 4,882.13 Million USD by 2032, with a CAGR of 10.79% (2025-2032). Notably, the China Human Prothrombin Complex market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Human prothrombin complex, also known as prothrombin complex concentrate (PCC), is a medication derived from blood plasma that contains concentrated forms of blood clotting factors. It is used in medical settings to manage bleeding disorders, particularly in situations where there is a deficiency or dysfunction of certain clotting factors. Prothrombin complex contains factors II (prothrombin), VII, IX, and X, along with proteins C and S. Administered intravenously, prothrombin complex can rapidly increase the levels of these clotting factors in the bloodstream, facilitating blood clotting and helping to control bleeding. This treatment is commonly employed in emergency situations, such as during surgeries, trauma, or for individuals with hereditary or acquired clotting factor deficiencies. The use of prothrombin complex is carefully monitored and tailored to the specific needs of the patient based on laboratory tests and clinical indications.
The major global manufacturers of Human Prothrombin Complex include Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Human Prothrombin Complex. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Prothrombin Complex market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Human Prothrombin Complex market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Prothrombin Complex industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Human Prothrombin Complex Include:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Human Prothrombin Complex Product Segment Include:
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Human Prothrombin Complex Product Application Include:
Hemophilia B
Vitamin K Deficiency
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Human Prothrombin Complex Industry PESTEL Analysis
Chapter 3: Global Human Prothrombin Complex Industry Porter's Five Forces Analysis
Chapter 4: Global Human Prothrombin Complex Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Human Prothrombin Complex Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Human Prothrombin Complex Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Human Prothrombin Complex Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Human Prothrombin Complex market size will reach 2,382.90 Million USD in 2025 and is projected to reach 4,882.13 Million USD by 2032, with a CAGR of 10.79% (2025-2032). Notably, the China Human Prothrombin Complex market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Human prothrombin complex, also known as prothrombin complex concentrate (PCC), is a medication derived from blood plasma that contains concentrated forms of blood clotting factors. It is used in medical settings to manage bleeding disorders, particularly in situations where there is a deficiency or dysfunction of certain clotting factors. Prothrombin complex contains factors II (prothrombin), VII, IX, and X, along with proteins C and S. Administered intravenously, prothrombin complex can rapidly increase the levels of these clotting factors in the bloodstream, facilitating blood clotting and helping to control bleeding. This treatment is commonly employed in emergency situations, such as during surgeries, trauma, or for individuals with hereditary or acquired clotting factor deficiencies. The use of prothrombin complex is carefully monitored and tailored to the specific needs of the patient based on laboratory tests and clinical indications.
The major global manufacturers of Human Prothrombin Complex include Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Human Prothrombin Complex. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Prothrombin Complex market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Human Prothrombin Complex market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Prothrombin Complex industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Human Prothrombin Complex Include:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Human Prothrombin Complex Product Segment Include:
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Human Prothrombin Complex Product Application Include:
Hemophilia B
Vitamin K Deficiency
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Human Prothrombin Complex Industry PESTEL Analysis
Chapter 3: Global Human Prothrombin Complex Industry Porter's Five Forces Analysis
Chapter 4: Global Human Prothrombin Complex Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Human Prothrombin Complex Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Human Prothrombin Complex Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Human Prothrombin Complex Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Human Prothrombin Complex Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Human Prothrombin Complex Product by Type
- 1.2.1 500 IU/Vial
- 1.2.2 600 IU/Vial
- 1.2.3 1000 IU/Vial
- 1.2.4 Others
- 1.3 Human Prothrombin Complex Product by Application
- 1.3.1 Hemophilia B
- 1.3.2 Vitamin K Deficiency
- 1.3.3 Others
- 1.4 Global Human Prothrombin Complex Market Revenue and Sales Analysis
- 1.4.1 Global Human Prothrombin Complex Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Human Prothrombin Complex Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Human Prothrombin Complex Market Sales Price Trend Analysis (2020-2032)
- 1.5 Human Prothrombin Complex Market Development Status and Trends
- 1.5.1 Human Prothrombin Complex Industry Development Status Analysis
- 1.5.2 Human Prothrombin Complex Industry Development Trends Analysis
- 2 Human Prothrombin Complex Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Human Prothrombin Complex Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Human Prothrombin Complex Market Analysis by Country
- 4.1 Global Human Prothrombin Complex Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Human Prothrombin Complex Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Human Prothrombin Complex Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Human Prothrombin Complex Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Human Prothrombin Complex Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Human Prothrombin Complex Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Human Prothrombin Complex Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Human Prothrombin Complex Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Human Prothrombin Complex Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Human Prothrombin Complex Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Human Prothrombin Complex Average Sales Price by Manufacturers (2021-2025)
- 5.2 Human Prothrombin Complex Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Human Prothrombin Complex Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Human Prothrombin Complex Market Analysis by Type
- 6.1 Global Human Prothrombin Complex Market Revenue Analysis by Type
- 6.1.1 Global Human Prothrombin Complex Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Human Prothrombin Complex Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Human Prothrombin Complex Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Human Prothrombin Complex Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Takeda
- 7.1.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Takeda Human Prothrombin Complex Product Portfolio
- 7.1.3 Takeda Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 CSL
- 7.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CSL Human Prothrombin Complex Product Portfolio
- 7.2.3 CSL Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Grifols
- 7.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Grifols Human Prothrombin Complex Product Portfolio
- 7.3.3 Grifols Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Octapharma
- 7.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Octapharma Human Prothrombin Complex Product Portfolio
- 7.4.3 Octapharma Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Hualan Biological
- 7.5.1 Hualan Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Hualan Biological Human Prothrombin Complex Product Portfolio
- 7.5.3 Hualan Biological Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Meheco Xinxing Pharma
- 7.6.1 Meheco Xinxing Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
- 7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Human Prothrombin Complex Industry Chain Analysis
- 8.2 Human Prothrombin Complex Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Human Prothrombin Complex Product Downstream Application Analysis
- 8.3.1 Global Human Prothrombin Complex Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Human Prothrombin Complex Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Human Prothrombin Complex Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Human Prothrombin Complex Typical Downstream Customers
- 8.5 Human Prothrombin Complex Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
